Amrita University launch wearable device for home monitoring of glucose and BP
PR94774
KOCHI, India, March 2, 2022 /PRNewswire=KYODO JBN/ --
- Patients can use the wearable, non-invasive device to measure six body
parameters including blood glucose, blood pressure, heart rate, blood oxygen,
respiratory rate and 6-lead ECG, from the comfort of their home
- The device, connected to the smart phone, can serve as a micro-bedside
monitor in rural clinics
Amrita University has developed a device for home-monitoring of glucose and
blood pressure. Amrita Spandanam, as the device is called, will be sold online
and through pharmacists across the country.
Photo -
https://mma.prnewswire.com/media/1756993/Amritapuri_Campus_Admin_Building_Drone.jpg
Developed and patented by the varsity's Centre for Wireless Networks and
Applications, it is a wearable, six-in-one device that is an excellent
replacement for a bedside monitor. It can be used to measure six body
parameters including blood glucose, blood pressure, heart rate, blood oxygen,
respiratory rate, and 6-lead ECG.
Said Dr Maneesha V Ramesh, the Provost of Amrita University who led the team of
researchers: "Amrita Spandanam is a revolutionary device that has bagged
several US patents, with results published in top scientific journals. It
offers a quick, easy, affordable and non-invasive way to monitor and detect
diabetes, cardiovascular diseases, hypertension, sleep apnea and allergy
attacks from the comfort of one's home. The product was extensively tested on
1000 patients at Amrita Hospital in Kochi and various remote clinics in Kerala.
Last year, these devices were successfully deployed at Amrita Hospital to
remotely monitor the progression of severity in COVID-19 patients."
Amrita Spandanam is connected to the patient's smartphone. The data is sent to
a secure hospital cloud which enables any doctor authorized by the patient to
access the vital parameters remotely from any location. The product also
integrates multiple -learning models that can predict the potential
deterioration of patients' health and provide early warning decision support to
doctors for acute hypotensive episodes, sepsis, sleep apnea, and atrial
fibrillation.
About Amrita University
Amrita partners with academic, industry and governmental institutions across
the world to accomplish human-centered, translational, and groundbreaking
research. Some of Amrita's partners include Harvard University, Columbia
University, King's College London, KTH - Royal Institute of Technology, VU
Amsterdam, the British Geological Society, University of Oxford, Italian
National Research Council, Deakin University, and the University of Tokyo. Sri
Mata Amritanandamayi Devi (Amma), a world-renowned humanitarian leader is the
founder, Chancellor, and guiding light of Amrita University.
Contact: Dr. Maneesha Ramesh, maneesha@amrita.edu
SOURCE Amrita University
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。